HEADER TRANSFERASE/TRANSFERASE INHIBITOR 12-SEP-13 3WIG
TITLE HUMAN MEK1 KINASE IN COMPLEX WITH CH5126766 AND MGAMP-PNP
COMPND MOL_ID: 1;
COMPND 2 MOLECULE: DUAL SPECIFICITY MITOGEN-ACTIVATED PROTEIN KINASE KINASE 1;
COMPND 3 CHAIN: A;
COMPND 4 SYNONYM: MAP KINASE KINASE 1, MAPKK 1, MKK1, ERK ACTIVATOR KINASE 1,
COMPND 5 MAPK/ERK KINASE 1, MEK 1;
COMPND 6 EC: 2.7.12.2;
COMPND 7 ENGINEERED: YES;
COMPND 8 OTHER_DETAILS: UNP RESIDUES 62-270, 303-393
SOURCE MOL_ID: 1;
SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS;
SOURCE 3 ORGANISM_COMMON: HUMAN;
SOURCE 4 ORGANISM_TAXID: 9606;
SOURCE 5 GENE: MAP2K1, MEK1, PRKMK1;
SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI;
SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562;
SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID
KEYWDS KINASE, KINASE INHIBITOR, ALLOSTERIC, TRANSFERASE-TRANSFERASE
KEYWDS 2 INHIBITOR COMPLEX
EXPDTA X-RAY DIFFRACTION
AUTHOR C.M.LUKACS,C.JANSON,V.SCHUCK
REVDAT 5 20-MAR-24 3WIG 1 REMARK LINK
REVDAT 4 25-DEC-19 3WIG 1 REMARK SEQADV
REVDAT 3 22-NOV-17 3WIG 1 REMARK
REVDAT 2 16-AUG-17 3WIG 1 SOURCE REMARK
REVDAT 1 04-JUN-14 3WIG 0
JRNL AUTH P.LITO,A.SABOROWSKI,J.YUE,M.SOLOMON,E.JOSEPH,S.GADAL,
JRNL AUTH 2 M.SABOROWSKI,E.KASTENHUBER,C.FELLMANN,K.OHARA,K.MORIKAMI,
JRNL AUTH 3 T.MIURA,C.LUKACS,N.ISHII,S.LOWE,N.ROSEN
JRNL TITL DISRUPTION OF CRAF-MEDIATED MEK ACTIVATION IS REQUIRED FOR
JRNL TITL 2 EFFECTIVE MEK INHIBITION IN KRAS MUTANT TUMORS
JRNL REF CANCER CELL V. 25 697 2014
JRNL REFN ISSN 1535-6108
JRNL PMID 24746704
JRNL DOI 10.1016/J.CCR.2014.03.011
REMARK 2
REMARK 2 RESOLUTION. 2.70 ANGSTROMS.
REMARK 3
REMARK 3 REFINEMENT.
REMARK 3 PROGRAM : CNS
REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE-
REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU,
REMARK 3 : READ,RICE,SIMONSON,WARREN
REMARK 3
REMARK 3 DATA USED IN REFINEMENT.
REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.70
REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 27.37
REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000
REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 1132132.000
REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000
REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 99.7
REMARK 3 NUMBER OF REFLECTIONS : 17775
REMARK 3
REMARK 3 FIT TO DATA USED IN REFINEMENT.
REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT
REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM
REMARK 3 R VALUE (WORKING + TEST SET) : 0.217
REMARK 3 R VALUE (WORKING SET) : 0.215
REMARK 3 FREE R VALUE : 0.250
REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000
REMARK 3 FREE R VALUE TEST SET COUNT : 896
REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.008
REMARK 3
REMARK 3 FIT/AGREEMENT OF MODEL WITH ALL DATA.
REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : 0.2910
REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : 0.2900
REMARK 3 FREE R VALUE (NO CUTOFF) : 0.311
REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : 5.000
REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : 896
REMARK 3 ESTIMATED ERROR OF FREE R VALUE (NO CUTOFF) : 0.0100
REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : 17775
REMARK 3
REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN.
REMARK 3 TOTAL NUMBER OF BINS USED : 17
REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.70
REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.76
REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL
REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 1000
REMARK 3 BIN R VALUE (WORKING SET) : 0.3353
REMARK 3 BIN FREE R VALUE : 0.3096
REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL
REMARK 3 BIN FREE R VALUE TEST SET COUNT : 43
REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL
REMARK 3
REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT.
REMARK 3 PROTEIN ATOMS : 2179
REMARK 3 NUCLEIC ACID ATOMS : 0
REMARK 3 HETEROGEN ATOMS : 83
REMARK 3 SOLVENT ATOMS : 16
REMARK 3
REMARK 3 B VALUES.
REMARK 3 FROM WILSON PLOT (A**2) : NULL
REMARK 3 MEAN B VALUE (OVERALL, A**2) : 56.85
REMARK 3 OVERALL ANISOTROPIC B VALUE.
REMARK 3 B11 (A**2) : -16.53000
REMARK 3 B22 (A**2) : -16.53000
REMARK 3 B33 (A**2) : 33.06000
REMARK 3 B12 (A**2) : -2.65000
REMARK 3 B13 (A**2) : 0.00000
REMARK 3 B23 (A**2) : 0.00000
REMARK 3
REMARK 3 ESTIMATED COORDINATE ERROR.
REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.35
REMARK 3 ESD FROM SIGMAA (A) : 0.49
REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00
REMARK 3
REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR.
REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.42
REMARK 3 ESD FROM C-V SIGMAA (A) : 0.53
REMARK 3
REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES.
REMARK 3 BOND LENGTHS (A) : 0.008
REMARK 3 BOND ANGLES (DEGREES) : 0.900
REMARK 3 DIHEDRAL ANGLES (DEGREES) : 20.40
REMARK 3 IMPROPER ANGLES (DEGREES) : 0.620
REMARK 3
REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED
REMARK 3
REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA
REMARK 3 MAIN-CHAIN BOND (A**2) : 1.170 ; 1.500
REMARK 3 MAIN-CHAIN ANGLE (A**2) : 2.020 ; 2.000
REMARK 3 SIDE-CHAIN BOND (A**2) : 1.900 ; 2.000
REMARK 3 SIDE-CHAIN ANGLE (A**2) : 2.980 ; 2.500
REMARK 3
REMARK 3 BULK SOLVENT MODELING.
REMARK 3 METHOD USED : FLAT MODEL
REMARK 3 KSOL : 0.35
REMARK 3 BSOL : 43.31
REMARK 3
REMARK 3 NCS MODEL : NULL
REMARK 3
REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT
REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL
REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL
REMARK 3
REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM
REMARK 3 PARAMETER FILE 2 : WATER_REP.PARAM
REMARK 3 PARAMETER FILE 3 : ION.PARAM
REMARK 3 PARAMETER FILE 4 : LIG.PARAM
REMARK 3 PARAMETER FILE 5 : ANP2.PARAM
REMARK 3 PARAMETER FILE 6 : NULL
REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP
REMARK 3 TOPOLOGY FILE 2 : WATER.TOP
REMARK 3 TOPOLOGY FILE 3 : ION.TOP
REMARK 3 TOPOLOGY FILE 4 : LIG.TOP
REMARK 3 TOPOLOGY FILE 5 : ANP2.TOP
REMARK 3 TOPOLOGY FILE 6 : NULL
REMARK 3
REMARK 3 OTHER REFINEMENT REMARKS: NULL
REMARK 4
REMARK 4 3WIG COMPLIES WITH FORMAT V. 3.30, 13-JUL-11
REMARK 100
REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 01-OCT-13.
REMARK 100 THE DEPOSITION ID IS D_1000096375.
REMARK 200
REMARK 200 EXPERIMENTAL DETAILS
REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION
REMARK 200 DATE OF DATA COLLECTION : 27-MAR-08
REMARK 200 TEMPERATURE (KELVIN) : 100
REMARK 200 PH : 4.2
REMARK 200 NUMBER OF CRYSTALS USED : 1
REMARK 200
REMARK 200 SYNCHROTRON (Y/N) : Y
REMARK 200 RADIATION SOURCE : APS
REMARK 200 BEAMLINE : 31-ID
REMARK 200 X-RAY GENERATOR MODEL : NULL
REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M
REMARK 200 WAVELENGTH OR RANGE (A) : 0.97929
REMARK 200 MONOCHROMATOR : NULL
REMARK 200 OPTICS : NULL
REMARK 200
REMARK 200 DETECTOR TYPE : CCD
REMARK 200 DETECTOR MANUFACTURER : MAR CCD 165 MM
REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO
REMARK 200 DATA SCALING SOFTWARE : SCALA 3.2.5, SCALEPACK
REMARK 200
REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 45559
REMARK 200 RESOLUTION RANGE HIGH (A) : 2.450
REMARK 200 RESOLUTION RANGE LOW (A) : 34.100
REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL
REMARK 200
REMARK 200 OVERALL.
REMARK 200 COMPLETENESS FOR RANGE (%) : 99.7
REMARK 200 DATA REDUNDANCY : 5.100
REMARK 200 R MERGE (I) : NULL
REMARK 200 R SYM (I) : 0.09100
REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 8.2000
REMARK 200
REMARK 200 IN THE HIGHEST RESOLUTION SHELL.
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.45
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.58
REMARK 200 COMPLETENESS FOR SHELL (%) : 99.5
REMARK 200 DATA REDUNDANCY IN SHELL : 4.70
REMARK 200 R MERGE FOR SHELL (I) : NULL
REMARK 200 R SYM FOR SHELL (I) : 1.09300
REMARK 200 <I/SIGMA(I)> FOR SHELL : 0.600
REMARK 200
REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH
REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT
REMARK 200 SOFTWARE USED: MOLREP
REMARK 200 STARTING MODEL: NULL
REMARK 200
REMARK 200 REMARK: NULL
REMARK 280
REMARK 280 CRYSTAL
REMARK 280 SOLVENT CONTENT, VS (%): 73.75
REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 4.68
REMARK 280
REMARK 280 CRYSTALLIZATION CONDITIONS: 7.5-10% PEG 8000, 0.2M NACL, 0.2M
REMARK 280 AMMONIUM SULFATE, 0.1M CITRATE BUFFER, PH 4.2, VAPOR DIFFUSION,
REMARK 280 SITTING DROP, TEMPERATURE 277K
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY
REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 31 2 1
REMARK 290
REMARK 290 SYMOP SYMMETRY
REMARK 290 NNNMMM OPERATOR
REMARK 290 1555 X,Y,Z
REMARK 290 2555 -Y,X-Y,Z+1/3
REMARK 290 3555 -X+Y,-X,Z+2/3
REMARK 290 4555 Y,X,-Z
REMARK 290 5555 X-Y,-Y,-Z+2/3
REMARK 290 6555 -X,-X+Y,-Z+1/3
REMARK 290
REMARK 290 WHERE NNN -> OPERATOR NUMBER
REMARK 290 MMM -> TRANSLATION VECTOR
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS
REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM
REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY
REMARK 290 RELATED MOLECULES.
REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000
REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000
REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000
REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000
REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 19.92133
REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000
REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000
REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 39.84267
REMARK 290 SMTRY1 4 -0.500000 0.866025 0.000000 0.00000
REMARK 290 SMTRY2 4 0.866025 0.500000 0.000000 0.00000
REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000
REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 5 0.000000 -1.000000 0.000000 0.00000
REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 39.84267
REMARK 290 SMTRY1 6 -0.500000 -0.866025 0.000000 0.00000
REMARK 290 SMTRY2 6 -0.866025 0.500000 0.000000 0.00000
REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 19.92133
REMARK 290
REMARK 290 REMARK: NULL
REMARK 300
REMARK 300 BIOMOLECULE: 1, 2
REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM
REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN
REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON
REMARK 300 BURIED SURFACE AREA.
REMARK 350
REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN
REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE
REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS
REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND
REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN.
REMARK 350
REMARK 350 BIOMOLECULE: 1
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A
REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000
REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000
REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 350
REMARK 350 BIOMOLECULE: 2
REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC
REMARK 350 SOFTWARE USED: PISA
REMARK 350 TOTAL BURIED SURFACE AREA: 3560 ANGSTROM**2
REMARK 350 SURFACE AREA OF THE COMPLEX: 24440 ANGSTROM**2
REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -10.0 KCAL/MOL
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A
REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000
REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000
REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 350 BIOMT1 2 1.000000 0.000000 0.000000 0.00000
REMARK 350 BIOMT2 2 0.000000 -1.000000 0.000000 0.00000
REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 39.84267
REMARK 465
REMARK 465 MISSING RESIDUES
REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE
REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN
REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.)
REMARK 465
REMARK 465 M RES C SSSEQI
REMARK 465 ASN A 79
REMARK 465 GLY A 80
REMARK 465 GLY A 81
REMARK 465 ASP A 299
REMARK 465 ALA A 300
REMARK 465 LYS A 301
REMARK 465 GLU A 302
REMARK 465 ASP A 303
REMARK 465 SER A 304
REMARK 465 ARG A 305
REMARK 465 LEU A 381
REMARK 465 ASN A 382
REMARK 465 GLN A 383
REMARK 465 PRO A 384
REMARK 465 SER A 385
REMARK 465 THR A 386
REMARK 465 PRO A 387
REMARK 465 THR A 388
REMARK 465 HIS A 389
REMARK 465 ALA A 390
REMARK 465 ALA A 391
REMARK 465 GLY A 392
REMARK 465 VAL A 393
REMARK 465 HIS A 394
REMARK 465 HIS A 395
REMARK 465 HIS A 396
REMARK 465 HIS A 397
REMARK 465 HIS A 398
REMARK 465 HIS A 399
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: TORSION ANGLES
REMARK 500
REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS:
REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;
REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).
REMARK 500
REMARK 500 STANDARD TABLE:
REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2)
REMARK 500
REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI-
REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400
REMARK 500
REMARK 500 M RES CSSEQI PSI PHI
REMARK 500 GLU A 63 87.98 62.14
REMARK 500 HIS A 185 -0.50 -140.95
REMARK 500 ARG A 190 -9.66 78.66
REMARK 500 ASP A 191 52.38 -148.26
REMARK 500
REMARK 500 REMARK: NULL
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS
REMARK 500
REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH
REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED
REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND
REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES.
REMARK 500 MODEL OMEGA
REMARK 500 PRO A 326 SER A 327 -147.62
REMARK 500
REMARK 500 REMARK: NULL
REMARK 620
REMARK 620 METAL COORDINATION
REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;
REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE):
REMARK 620
REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL
REMARK 620 MG A 402 MG
REMARK 620 N RES CSSEQI ATOM
REMARK 620 1 ASN A 196 OD1
REMARK 620 2 ASP A 209 OD2 105.8
REMARK 620 3 ANP A 401 O2B 94.1 152.1
REMARK 620 4 ANP A 401 O2A 169.9 83.6 75.8
REMARK 620 N 1 2 3
REMARK 800
REMARK 800 SITE
REMARK 800 SITE_IDENTIFIER: AC1
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ANP A 401
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC2
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MG A 402
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC3
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CHU A 403
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC4
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PG4 A 404
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC5
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL A 405
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC6
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL A 406
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC7
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL A 407
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC8
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL A 408
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC9
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL A 409
REMARK 900
REMARK 900 RELATED ENTRIES
REMARK 900 RELATED ID: 3ORN RELATED DB: PDB
REMARK 900 RELATED ID: 3OS3 RELATED DB: PDB
DBREF 3WIG A 63 302 UNP Q02750 MP2K1_HUMAN 62 270
DBREF 3WIG A 303 393 UNP Q02750 MP2K1_HUMAN 303 393
SEQADV 3WIG MET A 62 UNP Q02750 EXPRESSION TAG
SEQADV 3WIG HIS A 394 UNP Q02750 EXPRESSION TAG
SEQADV 3WIG HIS A 395 UNP Q02750 EXPRESSION TAG
SEQADV 3WIG HIS A 396 UNP Q02750 EXPRESSION TAG
SEQADV 3WIG HIS A 397 UNP Q02750 EXPRESSION TAG
SEQADV 3WIG HIS A 398 UNP Q02750 EXPRESSION TAG
SEQADV 3WIG HIS A 399 UNP Q02750 EXPRESSION TAG
SEQRES 1 A 307 MET GLU LEU LYS ASP ASP ASP PHE GLU LYS ILE SER GLU
SEQRES 2 A 307 LEU GLY ALA GLY ASN GLY GLY VAL VAL PHE LYS VAL SER
SEQRES 3 A 307 HIS LYS PRO SER GLY LEU VAL MET ALA ARG LYS LEU ILE
SEQRES 4 A 307 HIS LEU GLU ILE LYS PRO ALA ILE ARG ASN GLN ILE ILE
SEQRES 5 A 307 ARG GLU LEU GLN VAL LEU HIS GLU CYS ASN SER PRO TYR
SEQRES 6 A 307 ILE VAL GLY PHE TYR GLY ALA PHE TYR SER ASP GLY GLU
SEQRES 7 A 307 ILE SER ILE CYS MET GLU HIS MET ASP GLY GLY SER LEU
SEQRES 8 A 307 ASP GLN VAL LEU LYS LYS ALA GLY ARG ILE PRO GLU GLN
SEQRES 9 A 307 ILE LEU GLY LYS VAL SER ILE ALA VAL ILE LYS GLY LEU
SEQRES 10 A 307 THR TYR LEU ARG GLU LYS HIS LYS ILE MET HIS ARG ASP
SEQRES 11 A 307 VAL LYS PRO SER ASN ILE LEU VAL ASN SER ARG GLY GLU
SEQRES 12 A 307 ILE LYS LEU CYS ASP PHE GLY VAL SER GLY GLN LEU ILE
SEQRES 13 A 307 ASP SER MET ALA ASN SER PHE VAL GLY THR ARG SER TYR
SEQRES 14 A 307 MET SER PRO GLU ARG LEU GLN GLY THR HIS TYR SER VAL
SEQRES 15 A 307 GLN SER ASP ILE TRP SER MET GLY LEU SER LEU VAL GLU
SEQRES 16 A 307 MET ALA VAL GLY ARG TYR PRO ILE PRO PRO PRO ASP ALA
SEQRES 17 A 307 LYS GLU ASP SER ARG PRO PRO MET ALA ILE PHE GLU LEU
SEQRES 18 A 307 LEU ASP TYR ILE VAL ASN GLU PRO PRO PRO LYS LEU PRO
SEQRES 19 A 307 SER GLY VAL PHE SER LEU GLU PHE GLN ASP PHE VAL ASN
SEQRES 20 A 307 LYS CYS LEU ILE LYS ASN PRO ALA GLU ARG ALA ASP LEU
SEQRES 21 A 307 LYS GLN LEU MET VAL HIS ALA PHE ILE LYS ARG SER ASP
SEQRES 22 A 307 ALA GLU GLU VAL ASP PHE ALA GLY TRP LEU CYS SER THR
SEQRES 23 A 307 ILE GLY LEU ASN GLN PRO SER THR PRO THR HIS ALA ALA
SEQRES 24 A 307 GLY VAL HIS HIS HIS HIS HIS HIS
HET ANP A 401 31
HET MG A 402 1
HET CHU A 403 33
HET PG4 A 404 13
HET CL A 405 1
HET CL A 406 1
HET CL A 407 1
HET CL A 408 1
HET CL A 409 1
HETNAM ANP PHOSPHOAMINOPHOSPHONIC ACID-ADENYLATE ESTER
HETNAM MG MAGNESIUM ION
HETNAM CHU N-(3-FLUORO-4-{[4-METHYL-2-OXO-7-(PYRIMIDIN-2-YLOXY)-
HETNAM 2 CHU 2H-CHROMEN-3-YL]METHYL}PYRIDIN-2-YL)-N'-METHYLSULFURIC
HETNAM 3 CHU DIAMIDE
HETNAM PG4 TETRAETHYLENE GLYCOL
HETNAM CL CHLORIDE ION
HETSYN CHU CH5126766
FORMUL 2 ANP C10 H17 N6 O12 P3
FORMUL 3 MG MG 2+
FORMUL 4 CHU C21 H18 F N5 O5 S
FORMUL 5 PG4 C8 H18 O5
FORMUL 6 CL 5(CL 1-)
FORMUL 11 HOH *16(H2 O)
HELIX 1 1 LYS A 65 ASP A 67 5 3
HELIX 2 2 LYS A 105 GLN A 117 1 13
HELIX 3 3 VAL A 118 CYS A 122 5 5
HELIX 4 4 SER A 151 GLY A 160 1 10
HELIX 5 5 PRO A 163 HIS A 185 1 23
HELIX 6 6 LYS A 193 SER A 195 5 3
HELIX 7 7 SER A 213 ALA A 221 1 9
HELIX 8 8 ASN A 222 VAL A 225 5 4
HELIX 9 9 GLU A 234 GLY A 238 5 5
HELIX 10 10 SER A 242 GLY A 260 1 19
HELIX 11 11 ALA A 309 GLU A 320 1 12
HELIX 12 12 SER A 331 LEU A 342 1 12
HELIX 13 13 ASP A 351 VAL A 357 1 7
HELIX 14 14 HIS A 358 GLU A 367 1 10
HELIX 15 15 ASP A 370 GLY A 380 1 11
SHEET 1 A 5 PHE A 69 GLY A 76 0
SHEET 2 A 5 VAL A 83 HIS A 88 -1 O LYS A 85 N ILE A 72
SHEET 3 A 5 VAL A 94 HIS A 101 -1 O ARG A 97 N PHE A 84
SHEET 4 A 5 GLU A 139 GLU A 145 -1 O MET A 144 N ALA A 96
SHEET 5 A 5 PHE A 130 SER A 136 -1 N PHE A 134 O SER A 141
SHEET 1 B 2 ILE A 197 VAL A 199 0
SHEET 2 B 2 ILE A 205 LEU A 207 -1 O LYS A 206 N LEU A 198
LINK OD1 ASN A 196 MG MG A 402 1555 1555 2.11
LINK OD2 ASP A 209 MG MG A 402 1555 1555 2.18
LINK O2B ANP A 401 MG MG A 402 1555 1555 2.02
LINK O2A ANP A 401 MG MG A 402 1555 1555 2.19
CISPEP 1 ILE A 264 PRO A 265 0 -1.27
SITE 1 AC1 15 LEU A 75 ALA A 77 GLY A 78 ALA A 96
SITE 2 AC1 15 LYS A 98 GLU A 145 MET A 147 SER A 151
SITE 3 AC1 15 GLN A 154 LYS A 193 SER A 195 ASN A 196
SITE 4 AC1 15 LEU A 198 ASP A 209 MG A 402
SITE 1 AC2 3 ASN A 196 ASP A 209 ANP A 401
SITE 1 AC3 17 LEU A 119 VAL A 128 GLY A 129 ILE A 142
SITE 2 AC3 17 MET A 144 HIS A 189 ARG A 190 ASP A 191
SITE 3 AC3 17 ASP A 209 PHE A 210 GLY A 211 VAL A 212
SITE 4 AC3 17 SER A 213 LEU A 216 ILE A 217 MET A 220
SITE 5 AC3 17 ASN A 222
SITE 1 AC4 4 GLY A 211 VAL A 212 GLY A 214 GLN A 215
SITE 1 AC5 3 ARG A 182 SER A 242 VAL A 243
SITE 1 AC6 1 THR A 227
SITE 1 AC7 1 PHE A 371
SITE 1 AC8 2 SER A 331 LEU A 332
SITE 1 AC9 1 HIS A 240
CRYST1 136.366 136.366 59.764 90.00 90.00 120.00 P 31 2 1 6
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 0.007333 0.004234 0.000000 0.00000
SCALE2 0.000000 0.008468 0.000000 0.00000
SCALE3 0.000000 0.000000 0.016732 0.00000